---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-23-005514"
form_type: "8-K"
ticker: "PMDI"
cik: "0000806517"
company_name: "PSYCHEMEDICS CORP"
filed_at: "2023-08-31T23:59:59+00:00"
generated_at: "2026-06-11T01:40:25.404173+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Psychemedics EVP Charles Doucot to depart Sept 15, 2023; severance per 2019 agreement

## Summary
- Executive Vice President Charles Doucot leaving effective September 15, 2023.
- Severance benefits follow terms of February 26, 2019 severance agreement.
- No replacement or further executive changes announced in the filing.

## SEC filing metadata
- accession: 0001171843-23-005514
- form_type: 8-K
- ticker: PMDI
- cik: 0000806517
- company_name: PSYCHEMEDICS CORP
- filed_at: 2023-08-31T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/806517/000117184323005514/0001171843-23-005514-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/806517/000117184323005514/f8k_083123.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-23-005514
- JSON: https://secwatch.observer/filing/0001171843-23-005514.json
- Plain text: https://secwatch.observer/filing/0001171843-23-005514.txt

## Key facts
- Executive change
  Charles Doucot departed as Executive Vice President at PSYCHEMEDICS CORP.
  - Action: leaving
  - Role: Executive Vice President
  source text: Charles Doucot, the Company’s Executive Vice President, will be leaving the Company effective September 15, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/806517/000117184323005514/0001171843-23-005514-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.